Donald J. Webber
Directeur Général chez Bridge to Life Ltd.
Profil
Donald J.
Webber currently works at Bridge to Life Ltd., as Chief Executive Officer from 2022.
Mr. Webber also formerly worked at Mitralign, Inc., as President & Chief Executive Officer from 2004 to 2006, C.
R.
Bard, Inc. (New Jersey), as Vice President-Manufacturing from 2007 to 2010, Novoste Corp., as Chief Operating Officer & Vice President, EKOS Corp., as Vice President-Operations & Quality Assurance from 2006 to 2007, SynCardia Systems LLC, as Chief Operating Officer from 2018 to 2019, and OptiScan Biomedical Corp., as Chief Operating Officer.
Mr. Webber received his Masters Business Admin degree from Nova Southeastern University, Inc. and undergraduate degree from State University of New York at Albany.
Postes actifs de Donald J. Webber
| Sociétés | Poste | Début |
|---|---|---|
Bridge to Life Ltd.
 Bridge to Life Ltd. Medical SpecialtiesHealth Technology Bridge to Life Ltd. is a company that focuses on improving organ transplants by developing new preservation solutions and technologies. Bridge to Life is based in Northbrook, IL and has subsidiaries in Canada. The company is a leading supplier of preservation solutions worldwide and are currently enrolling patients in a study to evaluate the safety and effectiveness of the Vitasmart system. The company also has devices in development for lung and heart perfusion. The company was founded in 2005, and Donald J. Webber has been the CEO of the company since 2022. | Directeur Général | 20/10/2022 |
Anciens postes connus de Donald J. Webber
| Sociétés | Poste | Fin |
|---|---|---|
| C.R. BARD | Corporate Officer/Principal | 01/08/2010 |
| Novoste Corp. | Directeur des opérations | 27/11/2007 |
EKOS Corp.
 EKOS Corp. Electronic Equipment/InstrumentsElectronic Technology EKOS Corp. povides ultrasound accelerated and fluid infusion catheters for diagnosis and therapy. The company was founded 1995 by Douglas R. Hansmann and Joseph E. Eichinger and is headquartered in Bothell, WA. | Directeur des opérations | 01/01/2007 |
Mitralign, Inc.
 Mitralign, Inc. Medical SpecialtiesHealth Technology Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA. | President | 04/04/2006 |
SynCardia Systems LLC
 SynCardia Systems LLC Medical SpecialtiesHealth Technology SynCardia Systems LLC engages in the manufacture of temporary total artificial heart. Its total artificial heart provides immediate, safe blood flow of up to 9.5 L/min through each ventricle. The company was founded by Marvin J. Slepian, Jack G. Copeland, and Richard G. Smith in 2001 and is headquartered in Tucson, AZ. | Directeur Général | - |
Formation de Donald J. Webber
| Nova Southeastern University, Inc. | Masters Business Admin |
| State University of New York at Albany | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
C. R. Bard, Inc. (New Jersey)
 C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology C. R. Bard, Inc. engages in designing, development, manufacturing, packaging, distribution, and sales of medical, surgical, diagnostic, and patient care devices. It sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Franklin Lakes, NJ. | Health Technology |
| Novoste Corp. | Health Technology |
EKOS Corp.
EKOS Corp. Electronic Equipment/InstrumentsElectronic Technology EKOS Corp. povides ultrasound accelerated and fluid infusion catheters for diagnosis and therapy. The company was founded 1995 by Douglas R. Hansmann and Joseph E. Eichinger and is headquartered in Bothell, WA. | Electronic Technology |
Mitralign, Inc.
Mitralign, Inc. Medical SpecialtiesHealth Technology Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA. | Health Technology |
SynCardia Systems LLC
SynCardia Systems LLC Medical SpecialtiesHealth Technology SynCardia Systems LLC engages in the manufacture of temporary total artificial heart. Its total artificial heart provides immediate, safe blood flow of up to 9.5 L/min through each ventricle. The company was founded by Marvin J. Slepian, Jack G. Copeland, and Richard G. Smith in 2001 and is headquartered in Tucson, AZ. | Health Technology |
Bridge to Life Ltd.
Bridge to Life Ltd. Medical SpecialtiesHealth Technology Bridge to Life Ltd. is a company that focuses on improving organ transplants by developing new preservation solutions and technologies. Bridge to Life is based in Northbrook, IL and has subsidiaries in Canada. The company is a leading supplier of preservation solutions worldwide and are currently enrolling patients in a study to evaluate the safety and effectiveness of the Vitasmart system. The company also has devices in development for lung and heart perfusion. The company was founded in 2005, and Donald J. Webber has been the CEO of the company since 2022. | Health Technology |
OptiScan Biomedical Corp.
 OptiScan Biomedical Corp. Medical SpecialtiesHealth Technology OptiScan Biomedical Corp. develops and provides continuous monitoring systems for hospital intensive care units. The company offers OptiScanner 5000, a bedside blood monitoring platform that provides plasma-based, automated monitoring of patients’ glucose levels without the need for calibration, as well as uses a disposable cartridge containing the fluid pathway for sampling, storing, processing, and analyzing blood. The company was founded by James R. Braig and Daniel S. Goldberger in 1994 and is headquartered in Hayward, CA. | Health Technology |